Calculates ATTR amyloidosis progression using the Neuropathy Impairment Score (NIS), FAS composite, polyneuropathy disability score, and cardiac biomarkers (NT-proBNP, troponin) to guide patisiran/inotersen dosing.
Calculates ATTR amyloidosis progression using the Neuropathy Impairment Score (NIS), FAS composite, polyneuropathy disability score, and cardiac biomarkers (NT-proBNP, troponin) to guide patisiran/inotersen dosing
Each component has a specific meaning:
Note: Interpret the attr progression result against the thresholds and context described above.
Enter the FAS composite, cardiac biomarkers (NT-proBNP, troponin) for the scenario you are assessing. Calculates ATTR amyloidosis progression using the Neuropathy Impairment Score (NIS), FAS composite, polyneuropathy disability score, and cardiac biomarkers (NT-proBNP, troponin) to guide patisiran/inotersen dosing. Use the attr progression result to inform your calculation.